Figure 1. The expression of matrix metalloproteinase-14 (MMP-14) in equal volumes (15 µl) of vitreous fluid samples obtained from patients with proliferative diabetic retinopathy (PDR) and from control patients with rhegmatogenous retinal detachment (RD) was determined with western blot analysis.